← Back to Search

Observational (blood collection, bone marrow aspirate) for Acute Myeloid Leukemia

N/A
Recruiting
Led By Talha Badar, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (at enrollment)
Awards & highlights

Study Summary

This study investigates the immune profile of patients receiving treatment with venetoclax plus azacitidine for acute myeloid leukemia (AML). Studying the information gathered from the immune profile from blood and bone marrow samples may help researchers understand the associated responses to the treatment of patients undergoing therapy of venetoclax plus azacitidine and create future immune based treatment approaches.

Eligible Conditions
  • Acute Myeloid Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (at enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Immune profile of treatment naive acute myeloid leukemia (AML) patients receiving azacitidine plus venetoclax chemotherapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (blood collection, bone marrow aspirate)Experimental Treatment3 Interventions
Patients undergo blood sample collection and bone marrow aspirate on study. Patients' medical records are reviewed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bone Marrow Aspirate
2015
Completed Phase 3
~40
Biospecimen Collection
2004
Completed Phase 2
~1730

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,767,003 Total Patients Enrolled
Talha Badar, M.D.Principal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
2021. "Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06279572.
All > Phoenix > Paid Studies Minneapolis
~29 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top